IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.679
EU - Europa 8.827
AS - Asia 5.064
SA - Sud America 935
AF - Africa 98
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.635
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.537
PL - Polonia 5.078
CN - Cina 1.703
SG - Singapore 1.542
IT - Italia 874
UA - Ucraina 824
BR - Brasile 789
DE - Germania 584
HK - Hong Kong 540
VN - Vietnam 526
FI - Finlandia 324
GB - Regno Unito 286
TR - Turchia 178
RU - Federazione Russa 167
IE - Irlanda 155
IN - India 152
FR - Francia 115
ID - Indonesia 97
ES - Italia 73
SE - Svezia 72
BD - Bangladesh 67
CA - Canada 64
AR - Argentina 61
NL - Olanda 53
BE - Belgio 48
MX - Messico 47
ZA - Sudafrica 46
CZ - Repubblica Ceca 45
JP - Giappone 41
IQ - Iraq 29
AT - Austria 28
EC - Ecuador 22
AU - Australia 20
MA - Marocco 19
VE - Venezuela 17
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
PK - Pakistan 14
CH - Svizzera 13
SA - Arabia Saudita 12
CL - Cile 11
GR - Grecia 11
IL - Israele 11
AZ - Azerbaigian 10
KE - Kenya 10
MY - Malesia 10
CO - Colombia 9
EE - Estonia 9
PH - Filippine 9
PY - Paraguay 9
EG - Egitto 8
KG - Kirghizistan 8
KR - Corea 8
LT - Lituania 8
NO - Norvegia 8
EU - Europa 7
JO - Giordania 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
DZ - Algeria 6
KZ - Kazakistan 6
LK - Sri Lanka 6
PA - Panama 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
BO - Bolivia 4
LA - Repubblica Popolare Democratica del Laos 4
MO - Macao, regione amministrativa speciale della Cina 4
AM - Armenia 3
BY - Bielorussia 3
HR - Croazia 3
LV - Lettonia 3
PS - Palestinian Territory 3
PT - Portogallo 3
TN - Tunisia 3
CR - Costa Rica 2
ET - Etiopia 2
LB - Libano 2
MD - Moldavia 2
SV - El Salvador 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
GD - Grenada 1
Totale 24.618
Salva come PNG Salva come JPEG
Città #
Warsaw 5.073
Fairfield 1.086
Ashburn 920
Singapore 737
Woodbridge 719
Houston 684
Jacksonville 610
Hong Kong 536
Ann Arbor 495
Seattle 448
Brescia 444
Cambridge 419
Chandler 385
Wilmington 363
Beijing 356
Princeton 279
Dong Ket 241
New York 232
Nanjing 199
Dearborn 198
Los Angeles 192
Helsinki 155
Dublin 150
Istanbul 139
Dallas 127
The Dalles 122
Munich 119
Ho Chi Minh City 101
Milan 94
São Paulo 88
Jakarta 81
Nanchang 77
Shanghai 77
Buffalo 76
Des Moines 74
Jinan 70
San Francisco 68
Shenyang 65
Changsha 62
Turku 60
Hebei 59
Chicago 58
Moscow 54
Phoenix 54
Hanoi 53
Council Bluffs 52
Madrid 50
San Diego 48
Brussels 46
Redondo Beach 45
London 44
Hangzhou 43
Santa Clara 40
Jiaxing 37
Boardman 34
Tianjin 34
Brooklyn 32
Tokyo 32
Guangzhou 31
Stockholm 31
Kunming 30
Johannesburg 29
Zhengzhou 29
Haikou 27
Lancaster 25
Orem 25
Rio de Janeiro 25
Nuremberg 24
Amsterdam 23
Washington 23
Denver 22
Ningbo 22
Atlanta 20
Brno 20
Poplar 20
Rome 19
San Mateo 19
Ankara 18
Chennai 18
Dhaka 18
Lappeenranta 18
Montreal 18
Olomouc 18
Toronto 18
Belo Horizonte 17
Boston 17
Augusta 16
Curitiba 16
Mexico City 16
Verona 16
Brasília 15
Charlotte 15
Da Nang 15
Hefei 15
Lanzhou 15
Taizhou 15
Tashkent 14
Kilburn 12
Leawood 12
Monmouth Junction 12
Totale 18.064
Salva come PNG Salva come JPEG
Nome #
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 385
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 356
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 303
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 300
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 294
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 291
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 287
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 285
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 281
Tumor angiogenesis revisited: Regulators and clinical implications 281
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 278
Claudin3 is localized outside the tight junctions in human carcinomas 275
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 274
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 267
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 265
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 264
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 262
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 260
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 255
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 253
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 250
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 250
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 248
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 247
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 242
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 241
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 241
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 239
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 234
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 233
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 229
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 226
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 225
Interactions between endothelial cells and HIV-1. 223
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 223
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 221
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 220
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 220
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 219
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 218
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 213
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 213
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 212
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 208
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 205
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 204
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 202
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 201
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 198
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 194
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 193
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 190
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 188
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 186
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 183
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 181
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 179
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 175
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 173
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 170
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 165
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 163
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 161
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 157
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 154
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 149
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 146
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 145
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 144
Insights on the receptor dynamics during the spreading of endothelial cells 144
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 140
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 139
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 139
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 136
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 135
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 135
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 134
CCL16 activates an angiogenic program in vascular endothelial cells 132
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 131
Vascular disrupting activity of combretastatin analogues 131
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 129
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 128
Dendritic cell-endothelial cell cross-talk in angiogenesis. 127
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 127
Simulation of VEGF receptor recruitment on ECs membrane 127
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 126
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 126
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 125
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 124
Role of VEGFs in metabolic disorders 124
Fibroblast growth factor-2 in angiogenesis 123
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 121
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 120
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 120
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 120
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 120
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 117
Totale 19.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.131 0 0 0 0 0 343 190 342 366 302 274 314
2021/20221.291 81 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20264.207 650 851 527 1.002 759 418 0 0 0 0 0 0
Totale 25.006